ISigaba 2, Okungahleliwe, Okungaboni Okubili, Okulawulwa I-Placebo, I-Dose-Ranging Study ukuhlola ukusebenza kahle nokuphepha kwamazinga omthamo we-BID we-BID elawulwa LY3556050 Kubabambiqhaza Abadala abane-Diabetic Peripheral Neuropathic Pain.
Kubuyekezwe ngo-
Jun 12, 2024